miRNA can be a part of both the onset and cure of Coronary heart disease.
Moataz Dowaidar
Abstract
Cardiovascular disease causes the worst destruction. The study suggests that miRNAs are involved in the cause, occurrence, and prognosis of CVD. Even though they were discovered in 1993, their functions have not been well understood; more recently, they are known to control gene expression as well as fine-tune many biochemical processes. A myriad of miRNAs contribute to the pathogenesis of coronary diseases. Most experiments on miRNA have shown that miRNA is either increased or decreased under various pathophysiological conditions, but its function in CVD remains a mystery. often suggested to be involved in the pathophysiology of CVD The discovery of disease biomarkers that are useful in the processing would highlight the relevance of miRNAs for diagnostics and therapy development of CVDs. During the early stages, the use of miRNAs as therapies has the potential to impact therapeutics. More refined technologies are also required to develop miRNA as biomarkers and treatments Indeed, additional regional and/population research is needed to address any possible challenges or issues. The introduction of new gene therapies discoveries is on the way.